Pictet Asset Management (Switzerland)’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $23.4M | Buy |
777,962
+166,864
| +27% | +$5.02M | 0.03% | 430 |
|
|
2023
Q1 | $22.1M | Buy |
611,098
+388,589
| +175% | +$14.1M | 0.03% | 438 |
|
|
2022
Q4 | $7.94M | Buy |
222,509
+58,661
| +36% | +$2.09M | 0.01% | 638 |
|
|
2022
Q3 | $5.55M | Buy |
163,848
+34,784
| +27% | +$1.18M | 0.01% | 708 |
|
|
2022
Q2 | $3.73M | Buy |
129,064
+15,264
| +13% | +$441K | 0.01% | 816 |
|
|
2022
Q1 | $3.68M | Sell |
113,800
-11,412
| -9% | -$369K | ﹤0.01% | 864 |
|
|
2021
Q4 | $3.65M | Sell |
125,212
-35,239
| -22% | -$1.03M | ﹤0.01% | 890 |
|
|
2021
Q3 | $4.28M | Buy |
+160,451
| New | +$4.28M | ﹤0.01% | 861 |
|